Calendar-year 2010 ended strongly as companies reported good growth in both industrial and life science end-markets in the calendar-year fourth quarter. Companies were also optimistic about 2011 growth prospects. For the eight businesses whose financial results are presented on pages 9–11, calendar-year fourth-quarter 2010 revenues increased 11.8%, or 7.2% organically. Illumina and Agilent Life Sciences […]
The US government enacted the $787 billion American Recovery and Reinvestment Act (ARRA) in early 2009. The ARRA provided $21.5 billion for R&D (see IBO 2/28/09). ARRA funding was required to be obligated by September 30, 2010, the end of the federal government’s fiscal year 2010. Although ARRA obligations have been completed, ARRA spending has […]
As reported in IBO’s February 15 issue, Danaher plans to acquire Beckman Coulter for $6.8 billion, or $83.50 per share. Other companies that reportedly bid for Beckman were the private equity combinations of Apollo Global Management and Carlyle Group, and TPG Capital and Blackstone. However, a new name emerged later in the month. Quoting anonymous […]
Japan’s total R&D expenditures declined for the second year in a row in fiscal 2010 (April 1, 2009–March 31, 2010). The country’s total R&D expenditures reached ¥17,246.3 billion ($185.4 billion = ¥93 = $1), a decrease of 8.3%. Total R&D expenditures as a percentage of GDP declined 0.18% to 3.62% in fiscal 2010. The figures […]
Thirteen of the 20 companies in the IBO Laboratory Sales Index reported fourth-quarter earnings before this issue’s publication. OI was removed following the acquisition by ITT in November (see IBO 9/15/10). Based on estimates for companies yet to report, fourth-quarter revenue for the Index improved 6.2%, including a loss of 0.2% from currency, to $5,912.9 […]
NanoString Technologies was founded in 2003 to develop a technology to detect and count large sets of target molecules in biological samples. Headquartered in Seattle, Washington, the company employs about 90 people and has raised more than $47 million since it was founded. NanoString Technologies launched its first commercial instrument, the nCounter Analysis System, in […]
Two companies whose lab automation businesses illustrate the evolution of the lab automation market and technologies are PerkinElmer and Agilent Technologies. Formerly, laboratory automation was primarily associated with high-throughput compound screening for drug discovery. Now, laboratory automation is an integrated feature of application-based workflows in both drug discovery and development. PerkinElmer’s Bio-discovery business includes lab […]
This year’s LabAutomation was the debut conference for the Society for Laboratory Automation and Screening (SLAS). Formed in July 2010 by the merger of the Association for Laboratory Automation and the Society for Biomolecular Sciences, the SLAS was created to take advantage of the organizations’ shared resources and opportunities, including global expansion and member diversity. […]
Ending two months of speculation, Danaher announced on February 7 an agreement to acquire Beckman Coulter (see page 2). The deal is valued at approximately $6.8 billion, including debt and net of cash acquired. This is approximately 1.8 times Beckman Coulter’s 2010 revenues. With the purchase, Danaher will become a major provider of in vitro […]
PerkinElmer’s EnSpire Multimode Plate Reader is the first benchtop detection platform to utilize a combination of optical label-free technology and labeled assays for the identification and characterization of potential new therapeutic targets. The EnSpire uses Corning’s Epic label-free technology, as well as absorbance, fluorescence intensity, luminescence and PerkinElmer’s Alpha technology. Achim von Leoprechting, vice president […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
